Biological drugs are the new darlings of medicine. In recent years, they have doubled treatment rates for several cancers, arthritis and Crohn's disease. But these medicines, which are large, complex molecules produced by living cells, carry hefty price tags, and now comprise eight of the world's top 10 money-spinning drugs. Here, Klein examines what would happen now that the National Health Service is substituting expensive biological drugs with cheaper knock-offs.
© 2001-2024 Fundación Dialnet · Todos los derechos reservados